‘Double whammy’ for Roche as manufacturing patent losses loom

ZURICH (Reuters) – Landmark Roche patents that helped launch the modern biotechnology era end next year, extinguishing a source of billions of dollars in income for the Swiss drugmaker and piling pressure on its new medicines to succeed.
Original Article

more recommended stories